These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2996149)

  • 41. [Platelet membrane glycoproteins and their role in the receptor activity of blood platelets].
    Pawłowska Z; Cierniewski C; Krzesłowska J; Koziołkiewicz W
    Postepy Biochem; 1988; 34(3):183-207. PubMed ID: 2855751
    [No Abstract]   [Full Text] [Related]  

  • 42. Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets.
    Plow EF; McEver RP; Coller BS; Woods VL; Marguerie GA; Ginsberg MH
    Blood; 1985 Sep; 66(3):724-7. PubMed ID: 3875376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of a monoclonal antibody against GPs IIb-IIIa on platelet aggregation and ATP secretion.
    Balduini CL; Sinigallia F; Damiani G; Bertolino G; Bisio A; Zocchi E
    Exp Hematol; 1986 Jun; 14(5):338-42. PubMed ID: 3011483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet interaction with vascular smooth muscle in synthesis of prostacyclin.
    Hechtman DH; Kroll MH; Gimbrone MA; Schafer AI
    Am J Physiol; 1991 May; 260(5 Pt 2):H1544-51. PubMed ID: 1903602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes.
    Niewiarowski S; Budzynski AZ; Morinelli TA; Brudzynski TM; Stewart GJ
    J Biol Chem; 1981 Jan; 256(2):917-25. PubMed ID: 6256372
    [No Abstract]   [Full Text] [Related]  

  • 48. Fibrinogen fragment D is a recognition site for release-related platelet aggregation.
    Agam G; Shohat O; Livne A
    Thromb Res; 1985 Mar; 37(6):629-38. PubMed ID: 3992532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thromboxane A2 receptor antagonism selectively reverses platelet aggregation.
    Le Breton GC; Venton DL
    Adv Prostaglandin Thromboxane Res; 1980; 6():497-503. PubMed ID: 7386283
    [No Abstract]   [Full Text] [Related]  

  • 52. Platelet prostaglandin production and its implications.
    Smith JB; Ingerman CM; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on platelets of patients with inherited platelet disorders suggest that collagen-induced fibrinogen binding to membrane receptors requires secreted ADP but not released alpha-granule proteins.
    Legrand C; Nurden AT
    Thromb Haemost; 1985 Oct; 54(3):603-6. PubMed ID: 3003952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of leukotriene C4 synthase in human platelets via receptor-mediated mechanisms.
    Edenius C; Tornhamre S; Näsman-Glaser B; Eriksson I; Björkholm S; Lindgren JA
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():333-5. PubMed ID: 7732865
    [No Abstract]   [Full Text] [Related]  

  • 57. Platelet membrane components and receptors.
    Niewiarowski S
    Haematologia (Budap); 1987; 20(1):3-14. PubMed ID: 3036672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.
    Plow EF; Marguerie GA
    J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
    Fitzpatrick FA; Pike JE
    Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.